ASH 2022 Conference Coverage

 

ASH 2022 Conference Coverage
R

ASH 2022 Phase III APPLY-PNH Study: Oral Monotherapy With Iptacopan Has Superior Efficacy to SoC Eculizumab/Ravulizumab & Favorable Safety in Pts With PNH and Residual Anemia

By ASH 2022 Conference Coverage FEATURING Regis de Latour
By ASH 2022 Conference Coverage FEATURING Regis de Latour
116 views
December 20, 2022
0 Comments
Login to view comments. Click here to Login

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay

Featured Video

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter
Benign Hematology
05:00
ASH 2022 Conference Coverage

Cognitive Impairment in Patients With ITP

Feat. C. Vladescu
37:56
ASH 2022 Conference Coverage

Updates on Thrombosis & COVID-19

Feat. B. Hunt
16:56
ASH 2022 Conference Coverage

ASH 2022: What's Hot in Sickle Cell Disease Research 2022

Feat. E. Klings
08:41
ASH 2022 Conference Coverage

ASH 2022 Long-Term Outcomes of Patients With TDT Followed Up to 8 Ye…

Feat. M. Walters
06:01
ASH 2022 Conference Coverage

ASH 2022: Mitapivat Improves Iron Overload in Patients With Pyruvate…

Feat. K. Kuo
05:42
ASH 2022 Conference Coverage

ASH 2022 Health-Related QOL in Patients With Hemophilia A or B With …

Feat. A. Shapiro
11:26
ASH 2022 Conference Coverage

ASH 2022 Phase 3, Multicenter, Double-Blinded, Placebo-Controlled, R…

Feat. C. Broome
11:03
ASH 2022 Conference Coverage

ASH 2022 Low-Molecular-Weight Heparin vs. Standard Pregnancy Care fo…

Feat. S. Middeldorp
21:11
ASH 2022 Conference Coverage

ASH 2022: Immune Response to SARS-CoV-2 and Vaccination

Feat. S. Crotty
07:35
ASH 2022 Conference Coverage

ASH 2022 Hydroxyurea Dosing in Very Young Children With Sickle Cell …

Feat. W. Wang
10:53
ASH 2022 Conference Coverage

ASH 2022 New Biological Insights on Clonal Evolution in Aplastic Ane…

Feat. A. Kulasekararaj
09:20
ASH 2022 Conference Coverage

ASH 2022 Phase III APPLY-PNH Study: Oral Monotherapy With Iptacopan …

Feat. R. de Latour
24:02
ASH 2022 Conference Coverage

ASH 2022 Controversies in the Prevention of VTE for Medical Inpatien…

Feat. A. Spyropoulos
04:37
ASH 2022 Conference Coverage

ASH 2022 Outcomes of Older Patients With Aplastic Anemia Treated Wit…

Feat. J. Senapati
12:56
ASH 2022 Conference Coverage

ASH 2022 Lentiviral-Mediated Gene Therapy for Adults and Children Wi…

Feat. A. Shah